Farms.com Home   News

Leaders Say Preserving Crop Insurance Is Number One Priority For Farm Bill

With the first congressional session of the year starting up in Washington D.C., there's a lot of ag issues on the slate. The Republican controlled Congress looks to take up regulation issues as well as a potential new Farm Bill.

Iowa Senator Chuck Grassley says the number one priority when writing the new farm bill he has for farmers this session is to preserve a vigorous crop insurance program. He says there's no safety net more valuable to farmers and taxpayers than crop insurance.

In the case of agricultural disasters, farmers are only covered 50 percent, Grassley says, "It not only saves the taxpayers money, because obviously if we didn't have crop insurance and you had disasters in agriculture, the taxpayers would be 100 percent of it. In addition to saving the taxpayers money, we also are encouraging to plan ahead and to manage risk and 95 percent of the farmers in Iowa do that."

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.